SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital is trending following a strong Q2 earnings report that showcased 250% year-over-year revenue growth, fueling optimism around its accelerating expansion into high-performance computing. The community is actively discussing the significant pipeline of new data center capacity and anticipated hyperscaler lease announcements, positioning APLD as a key player in the AI infrastructure sector. Despite some short-term price fluctuations attributed by many to market manipulation, a strong bullish sentiment persists for its long-term growth potential.

China Sxt Pharmaceuticals, Inc. operates as a holding company, which engages in the research, development, manufacture, marketing, and sales of traditional Chinese medicine pieces (TCMP). Its product categories include directly-oral, after-soaking-oral, fine, and regular TCMP. The firm distributes its product under the Suxuantang brand. The company was founded by Feng Zhou in 2005 and is headquartered in Taizhou, China.

China SXT Pharmaceuticals Inc

China SXT Pharmaceuticals is trending due to its announced strategic AI insights initiative for traditional Chinese medicine, which has ignited significant price volatility. Community discussion highlights extreme intraday swings, with traders actively scalping and debating whether it's a high-risk "China pump and dump" or a legitimate runner. It is heavily watched within the broader "China play" theme, drawing comparisons to other recent low-float, high-volatility Chinese stocks experiencing rapid movements.

Memecoin on Cronos launched by the Cro Crow community

crow with knife

Crow with Knife ($CAW) is trending with its highly engaged community actively promoting it as the next dominant multi-chain meme coin. The project highlights its deflationary burn mechanism across various bridges and strategic partnerships, fueling discussions around its organic growth. The community expresses an ambitious goal for $CAW to become the leading meme coin by surpassing established contenders like Dogecoin and Shiba Inu.

JasmyCoin is based on the ERC 20 standard. The token can also be used by an unspecified number of individuals and businesses to transfer tokens using digital devices as proof of value exchange or payment for services. By not limiting its usability, the token can have a wide range of purposes.

JasmyCoin

JasmyCoin is experiencing a significant upward price movement and surging trading volume, fueling intense community debate around its near-term trajectory. Proponents emphasize its foundational utility in Japan's digital identity and IoT sector, backed by ex-Sony leadership and regulatory compliance, as indicators of a sustained breakout. Conversely, skeptics caution that the rally could be another transient event given its historical volatility and past supply dilution.

flyExclusive, Inc. engages in owning and operating jet aircraft for private jet passengers. It manages all aspects of the customer experience, in-house maintenance, repair, and overhaul services, including paint, interiors, and avionics capabilities. The company was founded by Thomas James Segrave, Jr. in 2015 and is headquartered in Kinston, NC.

flyExclusive Inc. - Ordinary Shares - Class A

flyExclusive is trending following news of its authorized dealership agreement with Starlink, positioning the private jet operator to install high-speed satellite internet across its fleet and for third parties. This development is sparking intense community discussion, with many actively debating its low float and the potential for a significant short squeeze. Traders are keenly observing its volatility, anticipating further price action.

Moonlake Immunotherapeutics operates as a clinical-stage biotechnology company. It offers tri-specific Nanobody, Sonelokimab to address significant unmet needs in inflammatory skin and joint diseases. The company was founded by Kristian Reich, Jorge Santos da Silva, and Arnout Ploos van Amstel in 2021 and is headquartered in Zug, Switzerland.

MoonLake Immunotherapeutics - Ordinary Shares - Class A

MoonLake Immunotherapeutics

MoonLake Immunotherapeutics (MLTX) is trending after announcing positive FDA feedback, confirming its lead asset, sonelokimab, can proceed with a BLA submission for hidradenitis suppurativa without additional clinical trials. This regulatory clarity is widely seen as a significant de-risking event, fueling strong community speculation about a potential acquisition, particularly by Merck, at a substantial premium. Investors are actively discussing the company's long-term value and the cleared path to market for its inflammatory skin disease pipeline.

Ardelyx, Inc. is a biopharmaceutical company, which engages in the business of developing and commercializing biopharmaceutical products. The firm is also involved in developing a unique and innovative platform that enables the discovery of new biological mechanisms and pathways to develop potent and efficacious therapies that minimize the side effects and drug-drug interactions frequently encountered with traditional, systemically absorbed medicines. The company was founded by Dominique Charmot, Peter G. Schultz, and Jean M. Frechet in October 2007 and is headquartered in Waltham, MA.

Ardelyx Inc

ARDX is trending as investors digest the potential impact of Fosun Pharma's Wan Ti Le being included on China's National Reimbursement Drug List and analysts anticipate target price raises due to strong IBSRELA sales. The community is weighing potential revenue from China and speculating on milestone payments, while also discussing concerns about patent infringement and generic competition. Some investors express frustration with the stock's price movement despite positive developments, awaiting a CMS resolution.

Aclarion, Inc. is a healthcare technology company, which engages in the provision of Magnetic Resonance Spectroscopy (MRS), and a proprietary biomarker to optimize clinical treatments. It utilizes Artificial Intelligence to assist in quality control processes that flag spectroscopy data indicative of a poor MRS study. It offers NOCISCAN Suite, a revolutionary software suite that works with existing high field Magnetic Resonance systems and Magnetic Resonance Spectroscopy pulse sequence packages using an optimized protocol to conduct MRS exams of lumbar discs. The company was founded by James C. Peacock, David S. Bradford, and Jeffrey Lotz in 2008 and is headquartered in Broomfield, CO.

Aclarion Inc

Aclarion Inc. is trending following news of significant year-over-year growth in Nociscan scan volumes, paired with a strong debt-free balance sheet and an extended cash runway. The community is actively debating the potential for a substantial short squeeze, driven by the company's tight share structure and perceived undervaluation, though some observers note its volatile history.

Apple, Inc. engages in the design, manufacture, and sale of smartphones, personal computers, tablets, wearables and accessories, and other varieties of related services. It operates through the following geographical segments: Americas, Europe, Greater China, Japan, and Rest of Asia Pacific. The Americas segment includes North and South America. The Europe segment consists of European countries, as well as India, the Middle East, and Africa. The Greater China segment comprises China, Hong Kong, and Taiwan. The Rest of Asia Pacific segment includes Australia and Asian countries. Its products and services include iPhone, Mac, iPad, AirPods, Apple TV, Apple Watch, Beats products, AppleCare, iCloud, digital content stores, streaming, and licensing services. The company was founded by Steven Paul Jobs, Ronald Gerald Wayne, and Stephen G. Wozniak in April 1976 and is headquartered in Cupertino, CA.

Apple Inc

Apple is trending following a significant multi-day pullback, sparking intense debate among traders. Many are weighing its heavily oversold technicals against a perceived lack of immediate AI catalysts, especially as other tech giants lead in market cap and innovation. The community is actively discussing potential bounce opportunities, while others remain cautious about its near-term performance.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending after its preliminary Q4 results and future guidance projected a significant dip in DefenCath revenue due to anticipated reimbursement shifts, sparking a sharp sell-off and investor frustration. While many see the decline as an overreaction to a known temporary headwind, bullish voices emphasize compelling Real-World Evidence data for DefenCath's efficacy and the stock's deep undervaluation, noting strong institutional interest and future pipeline catalysts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Arq, Inc. (NASDAQ:ARQ) Given Consensus Recommendation of "Hold" by Brokerages

Arq, Inc. (NASDAQ:ARQ - Get Free Report) has been given a consensus recommendation of "Hold" by the five research firms that are currently covering the stock, MarketBeat.com reports. Two investment...

Marex Group plc Takes Position in Arq, Inc. $ARQ

Marex Group plc acquired a new stake in Arq, Inc. (NASDAQ:ARQ - Free Report) during the second quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 323,456 shares of...

ARQ (NASDAQ:ARQ) Director Buys $101,378.52 in Stock

Arq, Inc. (NASDAQ:ARQ - Get Free Report) Director Richard Campbell-Breeden bought 28,638 shares of ARQ stock in a transaction that occurred on Tuesday, November 11th. The stock was bought at an...

ARQ (NASDAQ:ARQ) Director Purchases $101,378.52 in Stock

Arq, Inc. (NASDAQ:ARQ - Get Free Report) Director Richard Campbell-Breeden bought 28,638 shares of the company's stock in a transaction on Tuesday, November 11th. The stock was bought at an average...

Robert Rasmus Purchases 50,000 Shares of ARQ (NASDAQ:ARQ) Stock

Arq, Inc. (NASDAQ:ARQ - Get Free Report) CEO Robert Rasmus purchased 50,000 shares of the firm's stock in a transaction that occurred on Monday, November 10th. The shares were bought at an average...

Canaccord Genuity Group Cuts ARQ (NASDAQ:ARQ) Price Target to $8.00

Canaccord Genuity Group dropped their target price on shares of ARQ from $11.00 to $8.00 and set a "buy" rating on the stock in a research report on Friday...

ARQ (NASDAQ:ARQ) Downgraded by Wall Street Zen to "Sell"

Wall Street Zen cut shares of ARQ from a "hold" rating to a "sell" rating in a report on Saturday...

ARQ (NASDAQ:ARQ) Announces Quarterly Earnings Results, Misses Estimates By $0.04 EPS

ARQ (NASDAQ:ARQ - Get Free Report) posted its quarterly earnings results on Wednesday. The company reported ($0.02) EPS for the quarter, missing analysts' consensus estimates of $0.02 by ($0.04). ARQ...

Arq, Inc. (ARQ) Reports Q3 Loss, Lags Revenue Estimates

Arq, Inc. (ARQ) delivered earnings and revenue surprises of -200.00% and -4.07%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Flotek Industries (FTK) Q3 Earnings and Revenues Top Estimates

Flotek Industries (FTK) delivered earnings and revenue surprises of +33.33% and +12.40%, respectively, for the quarter ended September 2025. Do the numbers hold clues to what lies ahead for the stock?

Arq, Inc. is a holding company. It engages in the provision of environmental and emission control equipment to the power generation industry. The company operates through the following Segments: Refined Coal and Advanced Purification Technologies. The Refined Coal segment includes the Tinuum Group, Tinuum Services, and GWN Manager. The Advanced Purification Technologies segment refers to the sale of Activated Carbon Injection and Dry Sorbent Injection equipment systems, chemical sales, consulting services, and other sales related to the reduction of emissions in the coal-fired electric generation process and the electric utility industry. The company was founded in 1996 and is headquartered in Greenwood Village, CO.

Arq Inc

SpaceX

Discord

OpenAI

Other - Comment Below

A few major private companies are being discussed as potential IPO candidates in 2026 — including SpaceX, Discord, Databricks, OpenAI, Anthropic, and Deel. IPO timelines can shift, but if one of these listings happens this year, which are you most excited to watch?

Which Potential 2026 IPO Are You Most Excited For?

ARQ
Arq Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Poll

Latest ARQ News

ARQArq Inc